HIGHLIGHTS
- What: The study shows a predominance of IgG4 in 88% of patients.
- Who: Inga Koneczny from the University Hospital Zürich, Switzerland have published the research: HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 disease, in the Journal: (JOURNAL)
- How: To exactly quantify the IS of anti-IgLON5 IgG4 (zQIgLON5-IgG4) in comparison to total IgG IS (zQTotal IgG) in CSF/serum pairs with available data for QAlb and QIgG and remaining sample volume the authors employed an innovative and sensitive strategy using IS z scores . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.